INCIDENCE OF GERMLINE BRCA 1 AND 2 MUTATED BREAST CANCER IN THE EU5

Author(s)

Kim RS¹, Peterson A¹, Isherwood A², Uppal H¹, Barlev A¹
¹Medivation, Inc., San Francisco, CA, USA, ²Decision Resources Group, London, UK

Presentation Documents

PCN41--strong-u-kim-rs-u-sup-1-sup-strong-peterson-a-sup-1-sup-isherwood-a-sup-2-sup-uppal-h-sup-1-sup-barlev-a-sup-1-sup-br-sup-1-sup-medivation-inc-san-francisco-ca-usa-sup-2-sup-decision-resources-group-london-uk

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCN41

Topic

Epidemiology & Public Health

Disease

Oncology

Explore Related HEOR by Topic

Epidemiology

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now